ah 13205 has been researched along with thromboxane a2 in 2 studies
| Studies (ah 13205) | Trials (ah 13205) | Recent Studies (post-2010) (ah 13205) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 16 | 0 | 1 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lydford, SJ; McKechnie, K | 1 |
| Barnes, PJ; Giembycz, MA; Meja, KK | 1 |
2 other study(ies) available for ah 13205 and thromboxane a2
| Article | Year |
|---|---|
Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biphenyl Compounds; Dinoprostone; Heptanoic Acids; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Prostaglandin Endoperoxides, Synthetic; Prostaglandins E, Synthetic; Prostanoic Acids; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Thromboxane A2; Trachea | 1994 |
Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Biphenyl Compounds; Dinoprostone; Drug Interactions; Epoprostenol; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Prostaglandin Antagonists; Prostaglandin Endoperoxides, Synthetic; Prostanoic Acids; Receptors, Prostaglandin; Thromboxane A2; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 1997 |